Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Orthomyxoviridae Infections | 5 | 2021 | 1001 | 1.51 | Why? |
| Sex Characteristics | 7 | 2021 | 1120 | 1.22 | Why? |
| Progesterone | 2 | 2020 | 106 | 0.83 | Why? |
| Sporozoites | 1 | 2019 | 17 | 0.82 | Why? |
| Estriol | 1 | 2018 | 5 | 0.78 | Why? |
| Amphiregulin | 1 | 2018 | 38 | 0.76 | Why? |
| Virus Physiological Phenomena | 1 | 2021 | 155 | 0.76 | Why? |
| Malaria Vaccines | 1 | 2019 | 90 | 0.73 | Why? |
| Contraceptives, Oral, Hormonal | 2 | 2020 | 42 | 0.71 | Why? |
| Cross Protection | 1 | 2019 | 373 | 0.66 | Why? |
| Respiratory Physiological Phenomena | 1 | 2018 | 157 | 0.66 | Why? |
| Contraceptive Agents | 1 | 2017 | 62 | 0.65 | Why? |
| Sex Factors | 10 | 2021 | 11014 | 0.62 | Why? |
| Hormone Replacement Therapy | 1 | 2017 | 146 | 0.60 | Why? |
| Gonadal Steroid Hormones | 1 | 2018 | 328 | 0.58 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2018 | 2984 | 0.58 | Why? |
| Epithelium | 1 | 2017 | 330 | 0.57 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.57 | Why? |
| Malaria, Falciparum | 1 | 2019 | 377 | 0.56 | Why? |
| Estradiol | 3 | 2021 | 250 | 0.54 | Why? |
| Endothelium | 1 | 2017 | 460 | 0.52 | Why? |
| Aging | 3 | 2020 | 3581 | 0.46 | Why? |
| Immunity | 3 | 2020 | 2651 | 0.43 | Why? |
| Pregnancy Complications | 2 | 2021 | 1388 | 0.42 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.38 | Why? |
| Influenza Vaccines | 3 | 2021 | 2941 | 0.37 | Why? |
| Rodent Diseases | 1 | 2008 | 115 | 0.33 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.32 | Why? |
| Estrogens | 2 | 2020 | 252 | 0.32 | Why? |
| Cytotoxicity, Immunologic | 1 | 2008 | 287 | 0.31 | Why? |
| Lung | 7 | 2021 | 31049 | 0.30 | Why? |
| Influenza A virus | 1 | 2017 | 2234 | 0.28 | Why? |
| Animals | 15 | 2021 | 78931 | 0.26 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.26 | Why? |
| Mice, Inbred C57BL | 3 | 2018 | 5542 | 0.25 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.24 | Why? |
| Progestins | 2 | 2020 | 43 | 0.23 | Why? |
| Mice | 6 | 2021 | 21357 | 0.22 | Why? |
| Iodine Radioisotopes | 1 | 2021 | 124 | 0.22 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.21 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.21 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.21 | Why? |
| Spleen | 2 | 2019 | 877 | 0.21 | Why? |
| Sociological Factors | 1 | 2020 | 106 | 0.21 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.20 | Why? |
| Acetamides | 1 | 2021 | 141 | 0.20 | Why? |
| Mice, Inbred C3H | 1 | 2019 | 102 | 0.20 | Why? |
| Plasmodium berghei | 1 | 2019 | 27 | 0.20 | Why? |
| Vaccination | 5 | 2021 | 19050 | 0.20 | Why? |
| Immunomodulation | 2 | 2020 | 1472 | 0.20 | Why? |
| Immunity, Innate | 5 | 2020 | 6570 | 0.19 | Why? |
| Dendritic Cells | 1 | 2008 | 1330 | 0.19 | Why? |
| Antibodies, Protozoan | 1 | 2019 | 121 | 0.19 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.18 | Why? |
| Female | 22 | 2021 | 380317 | 0.18 | Why? |
| Protozoan Proteins | 1 | 2019 | 205 | 0.18 | Why? |
| Immunologic Surveillance | 1 | 2018 | 69 | 0.18 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.18 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.18 | Why? |
| Interferon-gamma | 1 | 2008 | 2711 | 0.17 | Why? |
| Influenza, Human | 2 | 2019 | 10779 | 0.17 | Why? |
| Adaptive Immunity | 2 | 2020 | 2585 | 0.17 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.16 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.15 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.15 | Why? |
| Positron-Emission Tomography | 1 | 2021 | 802 | 0.15 | Why? |
| Pregnancy Complications, Infectious | 2 | 2021 | 11559 | 0.15 | Why? |
| Plasmodium falciparum | 1 | 2019 | 337 | 0.15 | Why? |
| Interleukin-1beta | 1 | 2021 | 992 | 0.15 | Why? |
| Epithelial Cells | 2 | 2018 | 3508 | 0.15 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.14 | Why? |
| Influenza B virus | 1 | 2021 | 815 | 0.14 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.14 | Why? |
| Pregnancy | 5 | 2021 | 23879 | 0.14 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.14 | Why? |
| Placebos | 1 | 2017 | 629 | 0.13 | Why? |
| Genetic Vectors | 1 | 2021 | 1600 | 0.13 | Why? |
| Male | 15 | 2021 | 367725 | 0.13 | Why? |
| Family Planning Services | 1 | 2017 | 236 | 0.13 | Why? |
| Pyrimidines | 1 | 2021 | 1557 | 0.13 | Why? |
| Inflammation | 3 | 2021 | 13255 | 0.13 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.12 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.12 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.12 | Why? |
| Testosterone | 1 | 2018 | 596 | 0.12 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.12 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.12 | Why? |
| Chemokines | 1 | 2018 | 1095 | 0.12 | Why? |
| Vaccines, Attenuated | 1 | 2017 | 952 | 0.12 | Why? |
| Humans | 23 | 2021 | 930598 | 0.11 | Why? |
| Anaphylaxis | 1 | 2021 | 940 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.11 | Why? |
| Immunity, Cellular | 3 | 2021 | 3614 | 0.11 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2019 | 5837 | 0.11 | Why? |
| Autoimmunity | 1 | 2018 | 841 | 0.11 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.11 | Why? |
| Precision Medicine | 1 | 2020 | 1477 | 0.10 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.10 | Why? |
| Nasal Mucosa | 1 | 2017 | 1218 | 0.10 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.10 | Why? |
| Vaccines | 2 | 2020 | 3692 | 0.10 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.10 | Why? |
| Integrin alpha2 | 1 | 2008 | 8 | 0.09 | Why? |
| CD11c Antigen | 1 | 2008 | 18 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.09 | Why? |
| Parasitic Diseases, Animal | 1 | 2008 | 6 | 0.09 | Why? |
| B7-2 Antigen | 1 | 2008 | 56 | 0.09 | Why? |
| Immune System | 1 | 2018 | 1479 | 0.09 | Why? |
| Hyaluronan Receptors | 1 | 2008 | 61 | 0.09 | Why? |
| Estrogen Receptor alpha | 1 | 2008 | 40 | 0.09 | Why? |
| Mice, Inbred Strains | 1 | 2008 | 136 | 0.09 | Why? |
| Animals, Laboratory | 1 | 2008 | 40 | 0.09 | Why? |
| Viruses | 1 | 2021 | 2238 | 0.09 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.08 | Why? |
| Baltimore | 1 | 2008 | 220 | 0.08 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.08 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.08 | Why? |
| Antimalarials | 1 | 2019 | 2505 | 0.08 | Why? |
| Bone Marrow Cells | 1 | 2008 | 186 | 0.08 | Why? |
| Seasons | 1 | 2019 | 4071 | 0.08 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.08 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.08 | Why? |
| Histocompatibility Antigens Class II | 1 | 2008 | 383 | 0.07 | Why? |
| Liver | 1 | 2019 | 4007 | 0.07 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.06 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.06 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Cell Differentiation | 1 | 2008 | 1338 | 0.06 | Why? |
| Arabidopsis Proteins | 1 | 2021 | 54 | 0.06 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.05 | Why? |
| Immunoglobulin Class Switching | 1 | 2021 | 133 | 0.05 | Why? |
| Selective Estrogen Receptor Modulators | 1 | 2020 | 65 | 0.05 | Why? |
| Estrogen Replacement Therapy | 1 | 2020 | 50 | 0.05 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.05 | Why? |
| Rats | 1 | 2008 | 2764 | 0.05 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
| Placenta Diseases | 1 | 2021 | 180 | 0.05 | Why? |
| Disease Models, Animal | 3 | 2021 | 10998 | 0.05 | Why? |
| Immunologic Memory | 2 | 2021 | 3362 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Fetal Blood | 1 | 2021 | 573 | 0.04 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.04 | Why? |
| Antigen-Presenting Cells | 1 | 2017 | 206 | 0.04 | Why? |
| United States | 2 | 2021 | 46150 | 0.04 | Why? |
| Adult | 4 | 2021 | 244371 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Immune Tolerance | 1 | 2020 | 608 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2017 | 640 | 0.04 | Why? |
| Interferon-beta | 1 | 2021 | 979 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.03 | Why? |
| Bacterial Infections | 1 | 2008 | 2229 | 0.03 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.03 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2017 | 572 | 0.03 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.03 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 1458 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.03 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.03 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.03 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.03 | Why? |
| Virus Diseases | 1 | 2008 | 3779 | 0.03 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.03 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Prevalence | 1 | 2008 | 25773 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
Klein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(186)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_